On one hand, some studies have indeed shown that lower serum EPO levels were associated with more severe COVID-19 and poor prognosis [20,21,22]; on the other hand, other ones show a very limited efficacy of the treatment [23,24]. This evidence concerns the gene EPO and COVID-19.